Loading companies…
Loading companies…
United States · Biotech · AI · Enterprise software
Building AI models to accelerate pre-clinical drug discovery
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series C | $400M | Avenir — Role not disclosedAvra Capital — Role not disclosedBaillie Gifford — Role not disclosedBain Capital Ventures — Role not disclosedBattery Ventures — Role not disclosedBDT & MSD — Role not disclosedDimension — Role not disclosedGeneral Catalyst — Role not disclosedGlade Brook — Role not disclosedIndex Ventures — Role not disclosedKleiner Perkins — Role not disclosedLachy Groom — Role not disclosedMenlo Ventures — Role not disclosedOak HC/FT — Role not disclosedOpenAI — Role not disclosedSapphire Ventures — Role not disclosedSequoia Capital — Role not disclosedThrive Capital — Role not disclosedYosemite — Role not disclosed |